Data2Life develops solutions to provide easy access to patient-centered real-world evidence (RWE) analytics. Data2Life emphasizes the patient voice, distilling and analyzing patient-generated data from various sources and integrating it into traditional datasets. The company built a B2B drug intelligence platform that yields mature products delivering holistic RWE, precise and personalized patient profiles, and predictive trends about their therapeutic journey. Data2Life invested heavily in artificial intelligence analytics, focusing on proprietary deep-learning algorithms for healthcare, cannabis, and drug development.